Chancellor’s fellow Professor, Biomedical engineer, Co-Director of Center for Surgical Bioengineering, Depts of Surgery and BME, University of California, Davis
@ActaBio@alyssa_panitch@UCDavisBME@UCDavisSurgery@shrinershosp@UCDavisMed Congratulations to our team on this exciting study that showed how our newly identified endothelial cell specific ligand, LXW7, could help improve endothelialization of the blood contact surface of the artificial materials.
Excited to share our new study on utilizing the LXW7 technology to improve revascularization and tissue regeneration and help large deep burn heal faster. Congratulations to our team here at the @ucdsurgerycsb@UCDavisSurgery@UCDavisHealth
Bioengineer @AijunWangLab has designed and tested a biomaterial scaffold that may help large deep burn wounds heal faster and reduce the need for skin grafting in patients with significant burns over their body. Learn more: https://t.co/PIB7RsAj9r
We are very grateful and proud to partner with @CIRMnews and @shrinershosp for the phase 2 of the CuRe trial! It has been such a privilege to have worked with my best scientific partner @DianaFarmerMD and our incredible team at @ucdsurgerycsb for the past decade on this project.
We are thrilled to share that a team of our researchers, led by pioneering fetal surgeon @DianaFarmerMD and bioengineer @AijunWangLab, has been awarded nearly $15M for groundbreaking work on a spina bifida treatment by @CIRMnews and @shrinershosp! https://t.co/FMfe3Dy0Qd
We are thrilled to share that a team of our researchers, led by pioneering fetal surgeon @DianaFarmerMD and bioengineer @AijunWangLab, has been awarded nearly $15M for groundbreaking work on a spina bifida treatment by @CIRMnews and @shrinershosp! https://t.co/FMfe3Dy0Qd
🥳🥳🥳Sharing a highly cited articles published in EVCNA, 2021.
📌Title: Bioengineered extracellular vesicle-loaded bioscaffolds for therapeutic applications in #regenerativemedicine
🔗Read online: https://t.co/B8duwzqRQt
@AijunWangLab@UCDavisMed
Excited to continue our teamwork effort into another exciting EV engineering project with @carney_lab and collaborate with Dr. Orin Bloch @OrinBloch. So proud of our team!
Despite their known benefits, extracellular vesicles are tough to work with in clinical applications due to their diversity in size and makeup. Researchers at UC Davis hope to change that. #UCDavisEngineering
https://t.co/MdVrkerjoE
Despite their known benefits, extracellular vesicles are tough to work with in clinical applications due to their diversity in size and makeup. Researchers at UC Davis hope to change that. #UCDavisEngineering
https://t.co/MdVrkerjoE
With the MPI @NIBIBgov R01 grant support, we are excited to expand our collaboration between our labs @carney_lab@TanLabUCD@AijunWangLab to answer some of the most challenging questions in the field and to advance our knowledge on extracellular vesicle biology and application
To better understand their inner workings and medical applications, @TanLabUCD, @AijunWangLab and @carney_lab will build extracellular vesicles like Legos in a new research project funded by @NIBIBgov.
Read the full story ➡️ https://t.co/B0G9wARBND
@ucdavis@UCDavisHealth
In this study, we will develop a lipid nanoparticle based non-viral gene editing approach to correct the dystrophin mutations and restore full-length dystrophin expression in DMD patients before birth.
We are excited to receive this new Quest award to develop a novel treatment for Duchenne muscular dystrophy patients before birth. This study will be conducted at @ucdsurgerycsb by a strong interdisciplinary team at @UCDavisResearch with Dr. Niren Murthy from UC Berkeley.
We are excited to receive this new Quest award to develop a novel treatment for Duchenne muscular dystrophy patients before birth. This study will be conducted at @ucdsurgerycsb by a strong interdisciplinary team at @UCDavisResearch with Dr. Niren Murthy from UC Berkeley.
Congrats @AijunWangLab on a $2 million grant from California’s stem cell agency to develop a cure to Duchenne muscular dystrophy using an in-utero gene-editing formula. Learn more about this cutting-edge research. #DMD@CIRMnews https://t.co/eyabFEeqYD
We are excited to receive this new Quest award to develop a novel treatment for Duchenne muscular dystrophy patients before birth. This study will be conducted at @ucdsurgerycsb by a strong interdisciplinary team at @UCDavisResearch with Dr. Niren Murthy from UC Berkeley.
Today we report in @NatureMedicine a study led by Christine & Jonathan Seidman’s lab in which we used adenine base editing in vivo to correct a common mutation that causes hypertrophic cardiomyopathy (HCM), a disease that occurs in ~1 in 500 people (1/8)